Medical device manufacturer UE LifeSciences Inc. of Philadelphia received market clearance from the FDA for its NoTouch BreastScan device. The contact-free breast-imaging tool was cleared by the FDA specifically for adjunctive diagnostic screening for breast cancer. The imaging system incorporates patent-pending dual-infrared detector design. The company says the tool dynamically analyzes temperature pixels from various infrared frames to create a real-time objective report for the physician. UE plans to offer NoTouch BreastScan services to clinics in the US beginning in the New York, New Jersey and Pennsylvania regions.
MORE FROM PHOTONICS MEDIA